Cosmax Q1 Revenue Exceeds Expectations, but Operating Margin Falls Short of Consensus

Overview

This report is Goldman Sachs' initial review of Korean cosmetics OEM giant Cosmax Inc. (192820.KS) Q1 2026 results. The report notes strong Q1 revenue performance exceeding Goldman's and market consensus, mainly driven by rebounding domestic sales and robust growth in global MNC orders. However, the operating margin of 7.8%, while meeting Goldman's expectations, fell short of the market consensus of 8.4%. The margin miss was attributed to declining color product orders and deteriorating profitability at Southeast Asian subsidiaries due to intensified competition. Although management guides for Q2 margin improvement, Goldman remains cautious about cash flow generation given accelerating color product declines, emerging cost pressures and ongoing capex needs, thus maintaining its Neutral rating.

Core views

Revenue demonstrates strong resilience with notable Korean market rebound. Cosmax achieved Q1 revenue of KRW 682 billion, up 16% YoY and 13% QoQ, exceeding Goldman's estimate by 5% and Bloomberg consensus by 3%. The growth was primarily driven by domestic Korean sales, which rebounded sharply from 4% YoY growth in Q4 2025 to 17%, mainly due to strong performance in global MNC client orders (up 30% YoY). US sales also showed steady upward momentum. Margins dragged by structural factors, below market consensus. Q1 operating profit was KRW 53 billion with a 7.8% operating margin. While this was essentially flat with Goldman's 7.9% estimate, it fell short of the 8.4% market consensus. The report attributes the margin miss to two factors: declining key color product orders (previously flagged) and deteriorating profitability at Southeast Asian subsidiaries due to intensifying competition. Notably, color product sales fell 11% YoY, decelerating faster than expected, directly pressuring overall profitability. Cost pressures delayed to Q2; positive guidance but cash flow concerns. Management noted raw and packaging material costs rose ~10% on average but had limited Q1 impact. However, they expect these cost increases to begin affecting results from Q2 as Cosmax will absorb part of the cost increases rather than fully passing them to customers. Despite this, management guides for Q2 margin improvement QoQ, supported by seasonal Korean sales growth and steady US trends. Goldman believes while strong global MNC orders provide good near-term revenue visibility, rapid color product deceleration, consequent profit pressure and ongoing capex needs continue to raise concerns about free cash flow generation.

Analysis framework

Goldman employed a typical 'volume-price decomposition' combined with 'segment/regional contribution analysis' to assess Cosmax's performance. First, by comparing actual revenue against internal estimates (GSe) and Bloomberg consensus, they quantified the revenue beat and dissected growth drivers, identifying 'domestic Korean sales' and 'global MNC orders' as core contributors. Second, for margin analysis, beyond the headline operating margin figure, they conducted attribution analysis to pinpoint margin deviations to micro-level factors like 'product mix changes' (color product deceleration) and 'regional competitive landscape' (SEA subsidiary profitability deterioration). Finally, incorporating management's commentary on cost pass-through (partial absorption) and future capex outlook, they comprehensively evaluated the company's cash flow generation capability to arrive at the Neutral rating conclusion. This analytical logic emphasizes balancing short-term revenue momentum against medium-long term profit quality and cash flow health.

Methodology notes

• Valuation MethodologyEV/EBITDA valuation

  EV/EBITDA Multiple Approach

  Goldman uses enterprise value multiple (EV/EBITDA) for valuation, applying the company's 5-year historical average multiple (8x) to forecasted 12-month EBITDA to derive the target price. This method is commonly used for capital-intensive or high-depreciation manufacturing firms, better reflecting core operating cash flow value while neutralizing capital structure and tax difference impacts.

• Industry Analysis FrameworkVolume-price decomposition

  Revenue Driver Breakdown

  The report decomposes revenue growth by region (Korea, US etc.) and customer type (global MNC vs others) to identify true growth sources and sustainability. For example, it notes the Korean sales rebound was mainly MNC-driven rather than pure domestic brand growth.

• Company Fundamental & Financial FrameworkProfit Quality Analysis

  Margin Deviation Attribution

  When actual margins deviate from expectations, the report deeply analyzes underlying structural reasons like product mix changes (shifts in high/low margin product proportions) and regional competitive dynamics, rather than stopping at surface-level numbers. This helps determine whether margin pressures are temporary or structural.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Cosmax Inc. (192820.KS)

  Direct Coverage

  Strengths

  Strong global MNC orders, rebounding domestic Korean sales, steady US sales trends, high near-term revenue visibility

  Weaknesses

  Color product deceleration faster than expected, SEA subsidiary profitability deterioration from competition, partial cost absorption, persistent capex needs pressuring cash flow

  Risks

  Capex exceeding expectations, changes in shareholder return strategy, slower-than-expected profit recovery, overseas K-beauty demand volatility, intensifying overseas ODM competition

Key data

• 1Q26 RevenueKRW 682 billionUp 16% YoY, 13% QoQ, exceeding Goldman estimate by 5% and Bloomberg consensus by 3%
• 1Q26 Operating Margin7.8%Met Goldman estimate (7.9%) but missed Bloomberg consensus (8.4%)
• Korean Sales Growth17% (yoy)Significant rebound from 4Q25's 4%, mainly driven by 30% YoY global MNC order growth
• Color Product Sales Growth-11% (yoy)Deceleration faster than expected, dragging overall profitability
• Raw/Packaging Cost IncreaseAverage 10%Limited Q1 impact, expected to emerge from Q2 with partial cost absorption by company
• 12-month Target PriceKRW 170,000Based on 8x NTM EV/EBITDA (5-year average multiple)

Impact & implications

The report views Cosmax's near-term revenue growth visibility as high, mainly supported by strong global MNC client orders. However, investors should be wary of structural weakening in color product demand and long-term margin erosion from intensifying overseas ODM competition. Additionally, as the company absorbs part of rising material costs and faces persistent capex needs, free cash flow generation may be constrained. Maintaining Neutral suggests current prices already fairly reflect these positives and negatives, lacking clear upside catalysts.

Risks

• Capital expenditure requirements higher/lower than expected, potentially tightening/loosening free cash flow
• Management changes in shareholder return strategy
• Profitability improvement faster/slower than expected
• Overseas K-beauty demand stronger/weaker than expected
• Intensification/easing of overseas ODM market competition

What to watch

• Q2 operating margin improvement QoQ
• Actual manifestation of raw/packaging cost increases in Q2
• Subsequent trends in color product sales
• Sustainability of global MNC orders
• Profitability changes at SEA subsidiaries